Published in Cent Eur J Public Health on March 01, 2008
Hysterosalpingographic features of cervical abnormalities: acquired structural anomalies. Br J Radiol (2015) 0.75
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine (2008) 4.82
Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA (2004) 4.01
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst (2009) 3.71
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA (2009) 3.28
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine (2012) 3.09
Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types. Cancer Cytopathol (2013) 2.04
[Role of the clinician in cytologic diagnosis]. Lijec Vjesn (2003) 1.91
Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer (2009) 1.80
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol (2006) 1.77
High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer (2012) 1.71
Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen (2011) 1.63
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis. Cancer Cytopathol (2012) 1.60
Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ (2005) 1.47
A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev (2010) 1.46
Integrated media presentation in multidisciplinary head and neck oncology meetings. Eur Arch Otorhinolaryngol (2008) 1.38
Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer (2011) 1.33
Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev (2011) 1.27
Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer (2013) 1.25
Cervical cancer screening policies and coverage in Europe. Eur J Cancer (2009) 1.23
Delivering on the promise: HPV vaccines and cervical cancer. Nat Rev Microbiol (2004) 1.21
Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR. PLoS One (2011) 1.21
Chapter 25: Education, training, and communication for HPV vaccines. Vaccine (2006) 1.19
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev (2004) 1.18
Nucleic acid tests for the detection of alpha human papillomaviruses. Vaccine (2012) 1.17
Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen (2005) 1.16
Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen (2012) 1.16
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer (2008) 1.13
Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. Eur J Cancer (2008) 1.12
Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol (2007) 1.11
Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol (2009) 1.10
Prepared for sudden cardiac arrest? A cross-sectional study of automated external defibrillators in amateur sport. Br J Sports Med (2013) 1.08
Mortality audit of the Finnish cervical cancer screening program. Int J Cancer (2012) 1.07
Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics. Coll Antropol (2010) 1.04
Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer (2010) 1.02
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Epidemiol Prev (2012) 1.01
Improving cervical cancer screening attendance in Finland. Int J Cancer (2014) 1.01
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. BJOG (2004) 1.01
Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol (2013) 1.01
Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations. Virchows Arch (2011) 1.00
A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: performance with 470,000 invitations. Int J Cancer (2005) 1.00
Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. Int J Cancer (2008) 0.99
Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health (2011) 0.99
Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer (2006) 0.97
Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes. Acta Oncol (2006) 0.96
Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Coll Antropol (2010) 0.96
The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments. Int J Cancer (2014) 0.96
Improving the quality of communication in organised cervical cancer screening programmes. Patient Educ Couns (2008) 0.96
European Commission's proposal for a council recommendation on cancer screening. BMJ (2003) 0.96
Ganglionic transmission in a vasomotor pathway studied in vivo. J Physiol (2010) 0.95
Prior knowledge of HPV status improves detection of CIN2+ by cytology screening. Am J Obstet Gynecol (2011) 0.95
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer (2006) 0.95
Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis. Eur J Cancer (2012) 0.95
Mortality among workers employed in the titanium dioxide production industry in Europe. Cancer Causes Control (2004) 0.94
A framework provided an outline toward the proper evaluation of potential screening strategies. J Clin Epidemiol (2013) 0.93
Age-specific effectiveness of the Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers Prev (2012) 0.93
High burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006). Arch Public Health (2011) 0.93
Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study. Am J Obstet Gynecol (2008) 0.92
Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies. J Natl Cancer Inst (2013) 0.92
Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia. BMC Womens Health (2011) 0.92
Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis. BMC Med Res Methodol (2007) 0.92
Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med (2012) 0.92
Process performance of cervical screening programmes in Europe. Eur J Cancer (2009) 0.92
Cancer free survival after CIN treatment: comparisons of treatment methods and histology. Gynecol Oncol (2007) 0.91
Effects of different phases of an invitational screening program on breast cancer incidence. Int J Cancer (2006) 0.91
Neonatal hemophagocytic lymphohistiocytosis--case report. Coll Antropol (2010) 0.91
Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. Eur J Cancer (2009) 0.91
Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping. Am J Obstet Gynecol (2009) 0.90
Graduating pharmacy students' perspectives on e-professionalism and social media. Am J Pharm Educ (2013) 0.90
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. Int J Cancer (2012) 0.90
Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland. Int J Cancer (2008) 0.90
What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer (2009) 0.90
Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region. Breast Cancer Res Treat (2009) 0.89
Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening. Int J Cancer (2008) 0.88
Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology. PLoS One (2011) 0.88
Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia. Tumori (2010) 0.88
Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology. Arch Pathol Lab Med (2012) 0.87
HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy. PLoS One (2011) 0.87
HPV-based cervical-cancer screening in China. Lancet Oncol (2010) 0.87
Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial. Obstet Gynecol (2008) 0.87
Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One (2011) 0.87
Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer. Breast Cancer Res Treat (2010) 0.86
Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia. Am J Obstet Gynecol (2002) 0.86
Cytologic diagnosis of pancreatic endocrine tumors by endoscopic ultrasound-guided fine-needle aspiration: a review. Diagn Cytopathol (2006) 0.86
Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions. Virchows Arch (2011) 0.86
Impact of genetic notification on smoking cessation: systematic review and pooled-analysis. PLoS One (2012) 0.85
Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiol Biomarkers Prev (2013) 0.85
Role of fine needle aspiration cytology in management of hepatocellular carcinoma: a single centre experience. Coll Antropol (2010) 0.85
Building health systems capacity in global health graduate programs: reflections from Australian educators. BMC Int Health Hum Rights (2012) 0.85
Pre-B-cell acute lymphoblastic leukemia with bulk extramedullary disease and chromosome 22 (EWSR1) rearrangement masquerading as Ewing sarcoma. Pediatr Blood Cancer (2010) 0.85
Urine immunocytology as a noninvasive diagnostic tool for acute kidney rejection: a single center experience. Coll Antropol (2010) 0.85
Barriers in cervical cancer screening programs in new European Union member states. Tumori (2010) 0.84
Mortality in a long-term follow-up after treatment of CIN. Int J Cancer (2010) 0.84
Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies. Eur J Cancer Prev (2013) 0.84